• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)

13.60 -0.72 (-5.03%)
Official Closing Price Updated: 7:00 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,944,905
Open 14.17
Bid (Size) 13.50 (1)
Ask (Size) 14.00 (10)
Prev. Close 14.32
Today's Range 13.49 - 14.39
52wk Range 12.80 - 15.53
Shares Outstanding 1,557,765,596
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Takeda Pharma Maintains Outlook Even As Vyvanse Generics Hit Sales
July 30, 2025
Takeda reported a 30% rise in Q1 profit and beat EPS estimates, offsetting Vyvanse losses with growth in oncology, plasma, and rare disease drugs. 
Via Benzinga
Earnings Scheduled For July 30, 2025
July 30, 2025
 
Via Benzinga

Performance

YTD
+2.6%
+2.6%
1 Month
-12.0%
-12.0%
3 Month
-11.1%
-11.1%
6 Month
+2.2%
+2.2%
1 Year
-0.4%
-0.4%

More News

Read More
Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression
July 30, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
Insights Ahead: Takeda Pharmaceutical's Quarterly Earnings
July 29, 2025
Via Benzinga
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
July 21, 2025
Via Investor's Business Daily
Earnings Scheduled For May 8, 2025
May 08, 2025
Via Benzinga
Takeda Receives FDA 510(k) Clearance for HyHubTM and HyHubTM Duo Devices to Simplify HYQVIA® Administration
July 21, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
July 14, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1
June 30, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
Takeda Announces New Assignments of Directors
June 25, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD
June 03, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera
June 01, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
Takeda and Nature Announce Call for Applications Now Open for 2026 Innovators in Science Award
May 27, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1
May 14, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform
May 12, 2025
Via Investor's Business Daily
Topics Government Stocks
Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs
May 08, 2025
Via Benzinga
Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress
May 08, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
BioLife Plasma Services Introduces the New Fresenius Kabi Adaptive Nomogram Across its U.S. Network of Plasma Donation Centers
May 05, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
Takeda Awards $13.8 Million to U.S. Nonprofit Partners to Promote Healthy Eating and Expand STEM Education
April 30, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients
April 02, 2025
Via Benzinga
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
March 27, 2025
Via Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
March 21, 2025
Via Benzinga
Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer
March 03, 2025
Via Benzinga
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
March 03, 2025
From Takeda Pharmaceutical Company Limited
Via Business Wire
Earnings Scheduled For January 30, 2025
January 30, 2025
Via Benzinga

Frequently Asked Questions

Is Takeda Pharmaceutical Company Limited American Depositary Shares (each publicly traded?
Yes, Takeda Pharmaceutical Company Limited American Depositary Shares (each is publicly traded.
What exchange does Takeda Pharmaceutical Company Limited American Depositary Shares (each trade on?
Takeda Pharmaceutical Company Limited American Depositary Shares (each trades on the New York Stock Exchange
What is the ticker symbol for Takeda Pharmaceutical Company Limited American Depositary Shares (each?
The ticker symbol for Takeda Pharmaceutical Company Limited American Depositary Shares (each is TAK on the New York Stock Exchange
What is the current price of Takeda Pharmaceutical Company Limited American Depositary Shares (each?
The current price of Takeda Pharmaceutical Company Limited American Depositary Shares (each is 13.60
When was Takeda Pharmaceutical Company Limited American Depositary Shares (each last traded?
The last trade of Takeda Pharmaceutical Company Limited American Depositary Shares (each was at 07/30/25 07:00 PM ET
What is the market capitalization of Takeda Pharmaceutical Company Limited American Depositary Shares (each?
The market capitalization of Takeda Pharmaceutical Company Limited American Depositary Shares (each is 21.19B
How many shares of Takeda Pharmaceutical Company Limited American Depositary Shares (each are outstanding?
Takeda Pharmaceutical Company Limited American Depositary Shares (each has 21B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap